Showing 1 to 1 of 1 results
elmundo.es
🌐 85% Global Worthiness


Dapagliflozin Improves Outcomes in Post-TAVI Aortic Stenosis Patients
A clinical trial involving 1,250 patients with severe aortic stenosis demonstrated that dapagliflozin, an SGLT-2 inhibitor, significantly reduced mortality and hospital readmissions for heart failure following transcatheter aortic valve implantation (TAVI), prompting calls for updated clinical guide...
Dapagliflozin Improves Outcomes in Post-TAVI Aortic Stenosis Patients
A clinical trial involving 1,250 patients with severe aortic stenosis demonstrated that dapagliflozin, an SGLT-2 inhibitor, significantly reduced mortality and hospital readmissions for heart failure following transcatheter aortic valve implantation (TAVI), prompting calls for updated clinical guide...
Progress
48% Bias Score
Good Health and Well-being
Showing 1 to 1 of 1 results